Abdullatip, Alisabri A.
HRN: 18-33-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2023
MUPIROCIN 2%, 15G (TUBE)
05/02/2023
05/08/2023
TOPICAL
Apply On Affected Areas
Bid
Nonheaing Wound, Cellulitis Left Nape.
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes